Baker Avenue Asset Management, LP - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
Baker Avenue Asset Management, LP ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$4,622
-27.2%
172
-3.4%
0.00%
Q2 2023$6,347
+45.3%
178
+3.5%
0.00%
Q1 2023$4,369
-37.4%
1720.0%0.00%
Q4 2022$6,976
-97.0%
172
-95.3%
0.00%
-100.0%
Q3 2021$229,000
-83.2%
3,680
-77.7%
0.01%
-83.3%
Q2 2021$1,366,000
+135.9%
16,501
+88.7%
0.08%
+122.9%
Q1 2021$579,0008,7440.04%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$33,272,17921.56%
Aquilo Capital Management, LLC 1,103,515$44,758,56816.81%
M28 Capital Management LP 143,900$5,836,5845.56%
WEALTH EFFECTS LLC 155,620$6,311,9513.60%
Evolutionary Tree Capital Management, LLC 92,095$3,735,3733.59%
Privium Fund Management B.V. 221,015$8,867,1223.36%
JOHNSON & JOHNSON 247,598$10,0432.92%
COMMODORE CAPITAL LP 462,111$18,7432.82%
Avidity Partners Management LP 1,375,000$55,770,0001.21%
Capital Impact Advisors, LLC 26,853$1,089,1581.06%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders